{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T07:36:30Z","timestamp":1772177790897,"version":"3.50.1"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2010,12,14]],"date-time":"2010-12-14T00:00:00Z","timestamp":1292284800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0000916","type":"journal-article","created":{"date-parts":[[2010,12,14]],"date-time":"2010-12-14T16:03:29Z","timestamp":1292342609000},"page":"e916","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":65,"title":["The Potential Economic Value of a Trypanosoma cruzi (Chagas Disease) Vaccine in Latin America"],"prefix":"10.1371","volume":"4","author":[{"given":"Bruce Y.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina M.","family":"Bacon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana L.","family":"Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyssa M.","family":"Willig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel R.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2010,12,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1590\/S0074-02762009000900023","article-title":"Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina.","volume":"104","author":"S Sosa-Estani","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ahj.2003.07.026","article-title":"Congestive heart failure in Latin America: the next epidemic.","volume":"147","author":"LA Cubillos-Garzon","year":"2004","journal-title":"Am Heart J"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1590\/S0066-782X1999000300001","article-title":"Chagas' heart disease.","volume":"72","author":"JA Marin Neto","year":"1999","journal-title":"Arq Bras Cardiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1590\/S1516-31801995000200003","article-title":"Epidemiology of Chagas' heart disease.","volume":"113","author":"DM Wanderley","year":"1995","journal-title":"Sao Paulo Med J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","article-title":"Chagas disease.","volume":"375","author":"A Rassi Jr","year":"2010","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"901","DOI":"10.4269\/ajtmh.2005.73.901","article-title":"Cost-effectiveness of Chagas disease interventions in latin america and the Caribbean: Markov models.","volume":"73","author":"LS Wilson","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1086\/648073","article-title":"New advances in the management of a long-neglected disease.","volume":"49","author":"JA Urbina","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1590\/S0074-02762007000900018","article-title":"Chagas disease: what is known and what is needed\u2013a background article.","volume":"102","author":"JR Coura","year":"2007","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1590\/S0036-46652002000100006","article-title":"Long term evaluation of etiological treatment of chagas disease with benznidazole.","volume":"44","author":"JR Cancado","year":"2002","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1590\/S0074-02761999000700081","article-title":"Interruption of Chagas disease transmission in the Andean countries: Colombia.","volume":"94","author":"F Guhl","year":"1999","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1371\/journal.pmed.0040332","article-title":"The challenges of Chagas Disease\u2013 grim outlook or glimmer of hope.","volume":"4","author":"RL Tarleton","year":"2007","journal-title":"PLoS Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"90520","DOI":"10.1155\/2007\/90520","article-title":"DNA Vaccines against Protozoan Parasites: Advances and Challenges.","volume":"2007","author":"E Dumonteil","year":"2007","journal-title":"J Biomed Biotechnol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1128\/IAI.00278-09","article-title":"Intranasal vaccinations with the trans-sialidase antigen plus CpG Adjuvant induce mucosal immunity protective against conjunctival Trypanosoma cruzi challenges.","volume":"78","author":"OK Giddings","year":"2010","journal-title":"Infect Immun"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.vaccine.2009.09.047","article-title":"Constructing target product profiles (TPPs) to help vaccines overcome post-approval obstacles.","volume":"28","author":"BY Lee","year":"2010","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ijcard.2006.03.004","article-title":"Clinical aspects of the Chagas' heart disease.","volume":"115","author":"G Punukollu","year":"2007","journal-title":"Int J Cardiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.1371\/journal.pntd.0000336","article-title":"The costs of preventing and treating chagas disease in Colombia.","volume":"2","author":"M Castillo-Riquelme","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e688","DOI":"10.1371\/journal.pntd.0000688","article-title":"Chagas cardiomyopathy in the context of the chronic disease transition.","volume":"4","author":"AI Hidron","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref18","article-title":"World Economic and Financial Surveys","year":"2010"},{"key":"ref19","article-title":"UNICEF \u2013 Colombia \u2013 Statistics","year":"2008"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-3156.2000.00527.x","article-title":"Health-seeking behaviour for child illness in Guatemala.","volume":"5","author":"N Goldman","year":"2000","journal-title":"Trop Med Int Health"},{"key":"ref21","article-title":"Colombia","year":"2008"},{"key":"ref22","article-title":"Global Burden of Disease 2004 Update: Disability Weights for Diseases and Conditions","year":"2004"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2471\/BLT.07.045096","article-title":"Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006\u20132015.","volume":"86","author":"L Wolfson","year":"2008","journal-title":"Bulletin of the World Health Organization"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0035-9203(98)90720-9","article-title":"A cost-benefit analysis of Chagas disease control in north-western Argentina.","volume":"92","author":"MA Basombrio","year":"1998","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0167-5273(01)00497-1","article-title":"The epidemiological features of heart failure in developing countries: a review of the literature.","volume":"80","author":"GF Mendez","year":"2001","journal-title":"Int J Cardiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1590\/S0074-02762009000400002","article-title":"Present situation and new strategies for Chagas disease chemotherapy: a proposal.","volume":"104","author":"JR Coura","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref27","article-title":"Global Health Statistics: A Compendium of Incidence, Prevalence and Mortality Estimates for Over 200 Conditions (The Global Burden of Disease and Injury)","author":"C Murray","year":"1996"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e488","DOI":"10.1371\/journal.pntd.0000488","article-title":"Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Medecins Sans Frontieres.","volume":"3","author":"O Yun","year":"2009","journal-title":"PLoS Negl Trop Dis"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0000916","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T22:33:59Z","timestamp":1559860439000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0000916"}},"subtitle":[],"editor":[{"given":"Alison P.","family":"Galvani","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2010,12,14]]},"references-count":28,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2010,12,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0000916","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.7975956.8347054","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,14]]}}}